oxacillin has been researched along with daptomycin in 38 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (13.16) | 18.7374 |
1990's | 2 (5.26) | 18.2507 |
2000's | 6 (15.79) | 29.6817 |
2010's | 21 (55.26) | 24.3611 |
2020's | 4 (10.53) | 2.80 |
Authors | Studies |
---|---|
Fasching, CE; Gerding, DN; Moody, JA; Peterson, LR; Sinn, LM | 1 |
Low, DE; McGeer, A; Poon, R | 1 |
Husson, M; Matsumoto, T; Van der Auwera, P | 1 |
Knapp, CC; Washington, JA | 1 |
Verbist, L | 1 |
Gilligan, PH; Hodinka, RL; Jack-Wait, K; Walden, TP; Wannamaker, N | 1 |
Garcia, R; Raad, I | 1 |
Houck, HJ; Rand, KH | 1 |
Bento, M; Lew, DP; Schaad, HJ; Vaudaux, P | 1 |
English, BK; Maryniw, EM; Meals, EA; Talati, AJ | 1 |
Baltch, AL; Bopp, LH; Michelsen, PB; Ritz, WJ; Smith, RP | 1 |
Decousser, JW; Doucet-Populaire, F; Gallon, O; Guillet-Caruba, C; Lamy, B; Laurent, F | 1 |
Eliopoulos, GM; Karchmer, AW; Moellering, RC; Pillai, SK; Venkataraman, L; Wennersten, C | 1 |
Bayer, AS; Boyle-Vavra, S; Daum, R; Jones, T; Xiong, YQ; Yang, SJ | 1 |
Chen, FJ; Huang, IW; Lauderdale, TL; Lee, CH; Wang, MC | 1 |
Bell, JM; Jones, RN; Sader, HS; Turnidge, JD | 1 |
Beisser, PS; Croes, S; Deurenberg, RH; Neef, C; Stobberingh, EE; Terporten, PH | 1 |
Diagre, D; Hussain, Z; John, MA; Milburn, S; Stuart, JI; Wilson, B | 1 |
Bierry, G; Dietemann, JL; Ehlinger, M; Jehl, F; Lefevre, S; Neuville, A; Robert, P; Ruimy, D; Sordet, C | 1 |
Biek, D; Costello, AJ; Critchley, IA; Diekema, DJ; Doern, GV; Dohrn, CL; Heilmann, KP; Kroeger, JS; Riahi, F; Richter, SS | 1 |
Bayer, AS; Chen, L; Kreiswirth, BN; McKinnell, J; Mishra, NN; Nast, CC; Rubio, A; Yeaman, MR | 1 |
Berti, AD; Girdaukas, GG; Hetzel, SJ; Rose, WE; Sakoulas, G; Wergin, JE | 1 |
Li, L; Liu, X; Liu, Y; Qu, Y; Wang, X; Zhao, X | 1 |
Chanda, PK; Mehta, S; Paul, A; Plata, KB; Riosa, S; Rosato, AE; Rosato, RR; Singh, C | 1 |
Andlovic, A; Avberšek, J; Krt, B; Lejko-Zupanc, T; Ocepek, M; Pirš, T; Rupnik, M; Zdovc, I | 1 |
Drew, RJ; Paulus, S | 1 |
Ferreira, TP; Gobbi, DD; Hofer, E; Matté, GR; Matté, MH; Moreno, AM; Moreno, LZ; Paixão, R; Raimundo, DC; Reis, CM | 1 |
Angelova, SN; Chernen'kaia, TV; Ershova, MG; Gostev, VV; Khokhlova, OE; Kruglov, AN; Molchanova, IV; Naumenko, ZS; Poletaeva, ED; Popenko, LN; Sidorenko, SV; Voroshilova, TM; Zakharova, IuA | 1 |
Miksza, KF; Morales, HM; Pecoit-Filho, R; Rocha, JL; Sakumoto, MH; Tuon, FF | 1 |
Bartolomeu, AR; Brito, CI; Camargo, CH; Cunha, ML; Oliveira, A; Pereira, VC; Pinheiro, L | 1 |
Fatouraei, M; Fenn, S; Foster, SJ; Haeusser, DP; Kelley, WL; Margolin, W; Martinez, MP; Renzoni, A; Roch, M; Rosato, AE; Rosato, RR; Turner, RD | 1 |
Abad, L; Benito, Y; Bes, M; Camus, C; Chidiac, C; Dupieux, C; Ferry, T; Laurent, F; Lustig, S; Trouillet-Assant, S; Valour, F | 1 |
Peyrusson, F; Tulkens, PM; Van Bambeke, F | 1 |
Chang, SC; Chen, PY; Lee, YC; Wang, JT | 1 |
de Carvalho, CCCR; Rosato, AE; Taglialegna, A | 1 |
Boonthaworn, K; Jayachandran, P; Lasek-Nesselquist, E; Ma, Z; Malik, M; Mathur, A; McDonough, KA; Mishra, S; O'Donnell, N; Pata, JD; Sui, H | 1 |
Bae, T; Bhowmick, A; Ghosh, A; Jain, S; Jeong, B | 1 |
Cunningham, SA; Patel, R; Vaillant, JJ | 1 |
38 other study(ies) available for oxacillin and daptomycin
Article | Year |
---|---|
Treatment evaluation of experimental staphylococcal infections: comparison of beta-lactam, lipopeptide, and glycopeptide antimicrobial therapy.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cefamandole; Cefoperazone; Cephalothin; Daptomycin; Disease Models, Animal; Female; Glycopeptides; Oxacillin; Peptides; Rabbits; Staphylococcal Infections; Sulbactam; Teicoplanin; Vancomycin | 1990 |
Activities of daptomycin and teicoplanin against Staphylococcus haemolyticus and Staphylococcus epidermidis, including evaluation of susceptibility testing recommendations.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Resistance, Microbial; Evaluation Studies as Topic; Glycopeptides; Microbial Sensitivity Tests; Oxacillin; Peptides; Staphylococcus; Staphylococcus epidermidis; Teicoplanin; Vancomycin | 1989 |
Intraphagocytic penetration of antibiotics.
Topics: 4-Quinolones; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Daptomycin; Microbial Sensitivity Tests; Neutrophils; Oxacillin; Peptides; Rifamycins | 1988 |
Antistaphylococcal activity of a cyclic peptide, LY146032, and vancomycin.
Topics: Anti-Bacterial Agents; Daptomycin; Humans; Microbial Sensitivity Tests; Oxacillin; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin | 1986 |
In vitro activity of LY146032, a new lipopeptide antibiotic, against gram-positive cocci.
Topics: Ampicillin; Anti-Bacterial Agents; Daptomycin; Kinetics; Microbial Sensitivity Tests; Oxacillin; Staphylococcus; Streptococcus; Vancomycin | 1987 |
Comparative in vitro activity of LY146032 (daptomycin), a new lipopeptide antimicrobial.
Topics: Ampicillin; Anti-Bacterial Agents; Clostridium; Daptomycin; Glycopeptides; Gram-Positive Bacteria; Humans; Listeria monocytogenes; Microbial Sensitivity Tests; Oxacillin; Peptides; Staphylococcus; Streptococcus; Teicoplanin; Vancomycin | 1987 |
In vitro study of the potential role of quinupristin/dalfopristin in the treatment of catheter-related staphylococcal infections.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Bacteremia; Catheterization, Central Venous; Cefamandole; Cephalosporins; Ciprofloxacin; Clindamycin; Daptomycin; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Neoplasms; Novobiocin; Oxacillin; Penicillins; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Teicoplanin; Vancomycin; Virginiamycin | 1996 |
Synergy of daptomycin with oxacillin and other beta-lactams against methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Daptomycin; Drug Synergism; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Penicillins; Staphylococcus aureus; Time Factors | 2004 |
Evaluation of high-dose daptomycin for therapy of experimental Staphylococcus aureus foreign body infection.
Topics: Animals; Anti-Bacterial Agents; Daptomycin; Foreign Bodies; Microbial Sensitivity Tests; Oxacillin; Rats; Staphylococcal Infections; Vancomycin | 2006 |
Diminished macrophage inflammatory response to Staphylococcus aureus isolates exposed to daptomycin versus vancomycin or oxacillin.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Cells, Cultured; Colony Count, Microbial; Daptomycin; Drug Interactions; Humans; Macrophages; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Nitric Oxide Synthase Type II; Oxacillin; Staphylococcus aureus; Tumor Necrosis Factor-alpha; Vancomycin | 2006 |
Antimicrobial activities of daptomycin, vancomycin, and oxacillin in human monocytes and of daptomycin in combination with gentamicin and/or rifampin in human monocytes and in broth against Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Combinations; Gentamicins; Humans; Microbial Sensitivity Tests; Monocytes; Oxacillin; Rifampin; Staphylococcus aureus; Vancomycin | 2007 |
In vitro activity of daptomycin against Staphylococci isolated from bacteremia and community-onset skin and soft tissue infections in France: data from two nationwide studies.
Topics: Anti-Bacterial Agents; Bacteremia; Coagulase; Colony Count, Microbial; Community-Acquired Infections; Daptomycin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; France; Humans; Microbial Sensitivity Tests; Oxacillin; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus; Treatment Outcome | 2009 |
Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacteriolysis; Colony Count, Microbial; Daptomycin; Humans; Microbial Sensitivity Tests; Microbial Viability; Octoxynol; Oxacillin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2009 |
Daptomycin-oxacillin combinations in treatment of experimental endocarditis caused by daptomycin-nonsusceptible strains of methicillin-resistant Staphylococcus aureus with evolving oxacillin susceptibility (the "seesaw effect").
Topics: Animals; Anti-Bacterial Agents; Daptomycin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Rabbits; Treatment Outcome | 2010 |
Development of daptomycin nonsusceptibility with heterogeneous vancomycin-intermediate resistance and oxacillin susceptibility in methicillin-resistant Staphylococcus aureus during high-dose daptomycin treatment.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Oxacillin; Oxazolidinones; Teicoplanin; Vancomycin Resistance | 2010 |
Antimicrobial activity and spectrum of daptomycin: results from the surveillance program in Australia and New Zealand (2008).
Topics: Anti-Bacterial Agents; Australia; Daptomycin; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; New Zealand; Oxacillin; Population Surveillance | 2010 |
Diminished in vitro antibacterial activity of oxacillin against clinical isolates of borderline oxacillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Daptomycin; Drug Resistance, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Oxacillin; Oxazolidinones; Penicillin Resistance; Penicillin-Binding Proteins; Plasmids; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2010 |
Susceptibility patterns of coagulase-negative staphylococci to several newer antimicrobial agents in comparison with vancomycin and oxacillin.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Daptomycin; DNA, Ribosomal; Linezolid; Lipoglycopeptides; Microbial Sensitivity Tests; Micrococcal Nuclease; Minocycline; Oxacillin; Oxazolidinones; Penicillin-Binding Proteins; Polymerase Chain Reaction; Staphylococcus; Tigecycline; Vancomycin | 2011 |
Septic arthritis: monitoring with USPIO-enhanced macrophage MR imaging.
Topics: Animals; Arthritis, Infectious; Contrast Media; Daptomycin; Dextrans; Disease Models, Animal; Female; Knee Joint; Macrophages; Magnetic Resonance Imaging; Magnetite Nanoparticles; Oxacillin; Prospective Studies; Rabbits | 2011 |
Activity of ceftaroline and epidemiologic trends in Staphylococcus aureus isolates collected from 43 medical centers in the United States in 2009.
Topics: Acetamides; Bacterial Toxins; Ceftaroline; Cephalosporins; Clindamycin; Daptomycin; Electrophoresis, Gel, Pulsed-Field; Erythromycin; Exotoxins; Leukocidins; Levofloxacin; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mupirocin; Ofloxacin; Oxacillin; Oxazolidinones; Polymerase Chain Reaction; Staphylococcus aureus; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; United States; Vancomycin | 2011 |
In vitro cross-resistance to daptomycin and host defense cationic antimicrobial peptides in clinical methicillin-resistant Staphylococcus aureus isolates.
Topics: alpha-Defensins; Antimicrobial Cationic Peptides; beta-Thromboglobulin; Daptomycin; Genotype; Gentamicins; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Polymyxin B; Vancomycin | 2011 |
Altering the proclivity towards daptomycin resistance in methicillin-resistant Staphylococcus aureus using combinations with other antibiotics.
Topics: Anti-Bacterial Agents; Cell Wall; Clarithromycin; Daptomycin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin | 2012 |
Inhibitors of reactive oxygen species accumulation delay and/or reduce the lethality of several antistaphylococcal agents.
Topics: 2,2'-Dipyridyl; Anti-Bacterial Agents; Aza Compounds; Daptomycin; Fluoroquinolones; Microbial Sensitivity Tests; Moxifloxacin; Oxacillin; Quinolines; Reactive Oxygen Species; Staphylococcus aureus; Thiourea; Time Factors | 2012 |
β-Lactams increase the antibacterial activity of daptomycin against clinical methicillin-resistant Staphylococcus aureus strains and prevent selection of daptomycin-resistant derivatives.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Daptomycin; DNA; Drug Resistance, Bacterial; Drug Synergism; Imipenem; Insecta; Larva; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mutation; Nafcillin; Oxacillin; Staphylococcal Infections | 2012 |
Antimicrobial susceptibility of animal and human isolates of Clostridium difficile by broth microdilution.
Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Daptomycin; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Microbial Sensitivity Tests; Oxacillin | 2013 |
Comparison of Sensititre microdilution method to other standard methods for susceptibility testing of coagulase-negative staphylococci from paediatric blood cultures.
Topics: Anti-Bacterial Agents; Cefoxitin; Ciprofloxacin; Clindamycin; Daptomycin; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Oxacillin; Staphylococcus epidermidis; Staphylococcus hominis; Tetracycline; Vancomycin | 2014 |
Characterization of antibiotic resistance in Listeria spp. isolated from slaughterhouse environments, pork and human infections.
Topics: Abattoirs; Ampicillin; Animals; Anti-Bacterial Agents; Carbapenems; Clindamycin; Daptomycin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Genes, Bacterial; Humans; Listeria; Microbial Sensitivity Tests; Oxacillin; Swine; Tetracycline | 2014 |
[Estimation of MRSA susceptibility to oxacillin, cefoxitine, vancomycin and daptomycin].
Topics: Anti-Bacterial Agents; Cefoxitin; Daptomycin; Dose-Response Relationship, Drug; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Vancomycin | 2013 |
Modulation of inflammatory mediators during treatment of cellulitis with daptomycin or vancomycin/oxacillin.
Topics: Adolescent; Adult; Aged; Animals; Cellulitis; Cytokines; Daptomycin; Humans; Middle Aged; Oxacillin; Prospective Studies; Time Factors; Treatment Outcome; Vancomycin; Young Adult | 2015 |
Susceptibility Profile of Staphylococcus epidermidis and Staphylococcus haemolyticus Isolated from Blood Cultures to Vancomycin and Novel Antimicrobial Drugs over a Period of 12 Years.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Blood Culture; Brazil; Daptomycin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gene Expression; Hospitals, Teaching; Humans; Linezolid; Minocycline; Mutation; Oxacillin; Prevalence; Staphylococcal Infections; Staphylococcus epidermidis; Staphylococcus haemolyticus; Tigecycline; Vancomycin; Virginiamycin | 2016 |
Molecular Bases Determining Daptomycin Resistance-Mediated Resensitization to β-Lactams (Seesaw Effect) in Methicillin-Resistant Staphylococcus aureus.
Topics: Bacterial Proteins; beta-Lactams; Daptomycin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mutation; Oxacillin; Penicillin-Binding Proteins | 2017 |
Intraosteoblastic activity of daptomycin in combination with oxacillin and ceftaroline against MSSA and MRSA.
Topics: Anti-Bacterial Agents; Ceftaroline; Cell Line; Cephalosporins; Colony Count, Microbial; Daptomycin; Drug Synergism; Humans; Methicillin Resistance; Microbial Viability; Osteoblasts; Oxacillin; Staphylococcus aureus | 2017 |
Cellular Pharmacokinetics and Intracellular Activity of Gepotidacin against Staphylococcus aureus Isolates with Different Resistance Phenotypes in Models of Cultured Phagocytic Cells.
Topics: Acenaphthenes; Anti-Bacterial Agents; Azithromycin; Cell Line; Daptomycin; Heterocyclic Compounds, 3-Ring; Humans; Linezolid; Macrolides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Moxifloxacin; Oxacillin; Phagocytes; Staphylococcus aureus; THP-1 Cells; Vancomycin | 2018 |
A study on combination of daptomycin with selected antimicrobial agents: in vitro synergistic effect of MIC value of 1 mg/L against MRSA strains.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Synergism; Fosfomycin; Gentamicins; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Rifampin | 2019 |
Impact of PrsA on membrane lipid composition during daptomycin-resistance-mediated β-lactam sensitization in clinical MRSA strains.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Daptomycin; Lipoproteins; Membrane Lipids; Membrane Proteins; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin | 2021 |
Phenotypic and genetic changes associated with the seesaw effect in MRSA strain N315 in a bioreactor model.
Topics: beta-Lactams; Bioreactors; Daptomycin; Methicillin-Resistant Staphylococcus aureus; Oxacillin | 2022 |
Unravelling the physiological roles of mazEF toxin-antitoxin system on clinical MRSA strain by CRISPR RNA-guided cytidine deaminase.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Cytidine Deaminase; Daptomycin; Methicillin-Resistant Staphylococcus aureus; Mice; Oxacillin; RNA; Toxin-Antitoxin Systems; Vancomycin | 2022 |
Antibiotic susceptibility testing of Staphylococcus aureus using the Biolog OmniLog® system, a metabolic phenotyping assay.
Topics: Anti-Bacterial Agents; Daptomycin; Gentamicins; Linezolid; Microbial Sensitivity Tests; Oxacillin; Staphylococcal Infections; Staphylococcus aureus | 2022 |